Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 2C6H8O8.Tc |
| Molecular Weight | 515.1521 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[99Tc+4].O[C@@H]([C@H](O)[C@@H](O)C([O-])=O)[C@H](O)C([O-])=O.O[C@@H]([C@H](O)[C@@H](O)C([O-])=O)[C@H](O)C([O-])=O
InChI
InChIKey=KPEIQXMVJTXIKL-IQOUTWGWSA-J
InChI=1S/2C6H10O8.Tc/c2*7-1(3(9)5(11)12)2(8)4(10)6(13)14;/h2*1-4,7-10H,(H,11,12)(H,13,14);/q;;+4/p-4/t2*1-,2-,3-,4+;/m00./s1/i;;1+1
| Molecular Formula | Tc |
| Molecular Weight | 98.9063 |
| Charge | 4 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C6H8O8 |
| Molecular Weight | 208.1229 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | OSTEOLITE Approved UseUnknown Launch Date1977 |
|||
| Diagnostic | DRAXIMAGE MDP-10 Approved UseMDP-25 (Kit for the Preparation of Technetium Tc 99m Medronate) may be used as a bone imaging agent to delineate areas of altered osteogenesis. Launch Date1978 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:57:39 GMT 2023
by
admin
on
Fri Dec 15 15:57:39 GMT 2023
|
| Record UNII |
RXZ75FE8AA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
149751-64-4
Created by
admin on Fri Dec 15 15:57:39 GMT 2023 , Edited by admin on Fri Dec 15 15:57:39 GMT 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
162623760
Created by
admin on Fri Dec 15 15:57:39 GMT 2023 , Edited by admin on Fri Dec 15 15:57:39 GMT 2023
|
PRIMARY | |||
|
RXZ75FE8AA
Created by
admin on Fri Dec 15 15:57:39 GMT 2023 , Edited by admin on Fri Dec 15 15:57:39 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |